Jacobs Levy Equity Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-115,032
Closed -$7.23M 959
2024
Q3
$7.23M Buy
+115,032
New +$6.71M 0.03% 379
2024
Q1
Sell
-100,596
Closed -$7.94M 956
2023
Q4
$7.94M Sell
100,596
-3,158
-3% -$225K 0.04% 341
2023
Q3
$7.24M Buy
103,754
+75,559
+268% +$5.35M 0.04% 306
2023
Q2
$1.95M Hold
28,195
0.01% 574
2023
Q1
$2.1M Buy
+28,195
New +$2.36M 0.01% 567
2022
Q2
Sell
-2,338
Closed -$237K 1009
2022
Q1
$237K Buy
2,338
+52
+2% +$5.46K ﹤0.01% 947
2021
Q4
$236K Sell
2,286
-216,472
-99% -$20M ﹤0.01% 919
2021
Q3
$18.6M Sell
218,758
-227,721
-51% -$19.1M 0.13% 197
2021
Q2
$37.3M Buy
446,479
+437,523
+4,885% +$35.8M 0.25% 115
2021
Q1
$674K Buy
+8,956
New +$652K 0.01% 811
2017
Q2
Sell
-457,853
Closed -$35.9M 947
2017
Q1
$35.9M Sell
457,853
-78,453
-15% -$6.26M 0.73% 12
2016
Q4
$42.3M Buy
536,306
+210,840
+65% +$17.1M 0.82% 10
2016
Q3
$29M Sell
325,466
-250
-0.1% -$23.6K 0.52% 43
2016
Q2
$31.2M Buy
+325,716
New +$32.5M 0.65% 18
2013
Q3
Sell
-6,180
Closed -$353K 947
2013
Q2
$353K Buy
+6,180
New +$358K 0.01% 791

Other funds holding CVS

Jacobs Levy Equity Management's CVS Position: Q4 2024 in Review

Jacobs Levy Equity Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 115,032 shares — an estimated $7.23M sold.

Jacobs Levy Equity Management first reported a position in CVS in Q2 2013 and held it in 15 quarters. The position peaked at $42.3M in Q4 2016. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Jacobs Levy Equity Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 115,032 CVS Health shares in Q4 2024, an estimated $7.23M.
  • Jacobs Levy Equity Management first reported a position in CVS Health in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's CVS Health position peaked at $42.3M in Q4 2016.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.